Poniard Pharmaceuticals (PARD) Inactive 10-Q2006 Q2 Quarterly report

Filed: 14 Aug 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Good

New words: arose, Avenue, began, CA, California, Caroline, construction, consummated, contact, departure, EITF, Elliott, experienced, feet, Global, laboratory, Loewy, mailed, metropolitan, Occupancy, relapsed, requisite, reversal, reverse, Road, role, Shoreline, South, space, spilt, split, square, telephone, tenant

Removed: adjusted, adjustment, Alan, Aletheon, Anna, auction, beginning, behalf, buyer, ceased, Certification, Chairman, compensatory, consideration, contract, David, declare, declared, deemed, default, Diamond, Dina, director, discontinue, duly, equipment, evaluate, exhibit, Extreme, financed, fiscal, founded, Gerald, Glassberg, Harrison, herewith, identified, increasing, Index, Karlin, McMahon, negotiation, Nonemployee, offering, Parking, Pretarget, prosecution, recalculated, reference, registrant, request, Selig, sought, spent, Subsequent, suffered, thereunto, undersigned, unpaid, vacate, Wight

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

PARD similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Certification of Quarterly Report

I, Caroline M. Loewy, Chief Financial Officer of Poniard Pharmaceuticals, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350 that:

a. the Quarterly Report on Form 10-Q for the quarter ended June 30, 2006 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

b. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 14, 2006	By:	/s/ CAROLINE M. LOEWY
		Caroline M. Loewy

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.